Results 171 to 180 of about 937 (188)

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

New England Journal of Medicine, 2007
Janice P Dutcher, Anil Kapoor, David F Mcdermott   +2 more
exaly  

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

Lancet, The, 2012
Xavier G Thomas, Philippe Rousselot, Claude Preudhomme   +2 more
exaly  

Asfotase-alfa

Reactions Weekly
openaire   +1 more source

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

New England Journal of Medicine, 2019
Stuart J Connolly, Mark Crowther, John W. Eikelboom   +2 more
exaly  

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Lancet, The, 2001
exaly  

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

New England Journal of Medicine, 2009
Mark E Cooper, Dick de Zeeuw, Andrew S Levey   +2 more
exaly  

Asfotase-alfa/Naproxen/Paracetamol

Reactions Weekly
openaire   +1 more source

Abstract #714: Spurious Testosterone Laboratory Result in Patient Taking Asfotase Alfa

Endocrine Practice, 2017
Meredith Ross, Alina G. Sofronescu, Whitney Goldner, Eric Rush   +3 more
openaire   +1 more source

Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease

New England Journal of Medicine, 2006
Huiman Barnhart
exaly  

Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206

Journal of Clinical Oncology, 2008
Brian I Rini, Susan Halabi
exaly